Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Etidronate |
Bisphosphonate | Both (Solid & Hematologic) | ||
|
Molecule
Etidronate
Therapeutic Category
Bone-Modifying Agent
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Bisphosphonate |
||||
Etoposide |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Etoposide
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Etoposide Phosphate |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Etoposide Phosphate
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Evofosfamide |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Evofosfamide
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Exatecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Exatecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Exemestane |
Aromatase Inhibitor | Solid Tumour (Breast) | ||
|
Molecule
Exemestane
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
||||
Ezlopitant |
NK-1 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Ezlopitant
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
||||
Factor IX Concentrate |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Factor IX Concentrate
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Factor VIII Concentrate |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Factor VIII Concentrate
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Fadrozole |
Aromatase Inhibitor | Solid Tumour (Breast) | ||
|
Molecule
Fadrozole
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
||||
Fenretinide |
Retinoid / Arsenical | Hematologic (APL) / Solid Tumour | ||
|
Molecule
Fenretinide
Therapeutic Category
Differentiating Agent
Oncology Type
Hematologic (APL) / Solid Tumour
Drug Class / Mechanism
Retinoid / Arsenical |
||||
Fentanyl (Transdermal/IV) |
Opioid / Adjuvant Analgesic | Both (Solid & Hematologic) | ||
|
Molecule
Fentanyl (Transdermal/IV)
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
||||
EtidronateBone-Modifying Agent |
|
|
Therapeutic Category
Bone-Modifying Agent
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Bisphosphonate |
|
EtoposideCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
Etoposide PhosphateCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
EvofosfamideCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
ExatecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
ExemestaneHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
|
EzlopitantSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
NK-1 Receptor Antagonist |
|
Factor IX ConcentrateSupportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
Factor VIII ConcentrateSupportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
FadrozoleHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Aromatase Inhibitor |
|
FenretinideDifferentiating Agent |
|
|
Therapeutic Category
Differentiating Agent
Oncology Type
Hematologic (APL) / Solid Tumour
Drug Class / Mechanism
Retinoid / Arsenical |
|
Fentanyl (Transdermal/IV)Supportive Care (Analgesic) |
|
|
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
|